Tome Biosciences
About:
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
Website: https://tome.bio
Twitter/X: tome_bio
Top Investors: Alexandria Venture Investments, Andreessen Horowitz, ARCH Venture Partners, Google Ventures, Bruker
Description:
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
Total Funding Amount:
$213M
Headquarters Location:
Watertown, Massachusetts, United States
Founded Date:
2021-01-01
Contact Email:
hello(AT)tome.bio
Founders:
Jonathan Gootenberg, Omar Abudayyeh
Number of Employees:
101-250
Last Funding Date:
2023-12-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai